# Long-term Follow-up Study of BRL-101 for TDT

> **NCT06298630** · — · NOT_YET_RECRUITING · sponsor: **Bioray Laboratories** · enrollment: 45 (estimated)

## Conditions studied

- Thalassemia, Beta

## Interventions

- **OTHER:** Assessments

## Key facts

- **NCT ID:** NCT06298630
- **Lead sponsor:** Bioray Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-08
- **Primary completion:** 2038-08-20
- **Final completion:** 2038-10-15
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2024-03-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06298630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06298630, "Long-term Follow-up Study of BRL-101 for TDT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06298630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*